mesalamine has been researched along with Atherosclerosis in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cappello, M | 1 |
| Licata, A | 1 |
| Calvaruso, V | 1 |
| Bravatà, I | 1 |
| Aiello, A | 1 |
| Torres, D | 1 |
| Della Corte, V | 1 |
| Tuttolomondo, A | 1 |
| Perticone, M | 1 |
| Licata, G | 1 |
| Craxì, A | 1 |
| Cammà, C | 1 |
| Rungoe, C | 1 |
| Basit, S | 1 |
| Ranthe, MF | 1 |
| Wohlfahrt, J | 1 |
| Langholz, E | 1 |
| Jess, T | 1 |
2 other studies available for mesalamine and Atherosclerosis
| Article | Year |
|---|---|
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Biomarkers; Carotid Arteries; Carot | 2017 |
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
Topics: Adolescent; Adult; Aged; Atherosclerosis; Case-Control Studies; Cohort Studies; Denmark; Female; Fol | 2013 |